⌘K

Login Start Free

Home/Filings/4/0001019687-12-000626

4//SEC Filing

LYTLE PAUL J 4

Accession 0001019687-12-000626

CIK 0000704562other

View on SEC.gov Company Profile

Filed

Feb 20, 7:00 PM ET

Accepted

Feb 21, 8:17 PM ET

Size

5.3 KB

Accession

0001019687-12-000626

Insider Transaction Report

Form 4

Period: 2012-02-17

PEREGRINE PHARMACEUTICALS INCPPHM

Chief Financial Officer

Transactions

Award
Incentive Stock Options (right to buy)
2012-02-17+140,000→ 407,500 total
Exercise: $0.95From: 2012-05-17Exp: 2022-02-17→ Common Stock (140,000 underlying)

Footnotes (1)

[F1]This option vests quarterly over a two year period.

Documents

1 file

4
lytle_f4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

PEREGRINE PHARMACEUTICALS INC

CIK 0000704562

Entity typeother

Related Parties

1

filerCIK 0001244110

Filing Metadata

Form type: 4
Filed: Feb 20, 7:00 PM ET
Accepted: Feb 21, 8:17 PM ET
Size: 5.3 KB

View on SEC.gov